BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 33642283)

  • 1. Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
    Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
    World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
    Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
    Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas.
    Ma L; Shi Y; Li C; Deng B; Jiang J; Cao Y; Wang L; Li H
    Front Immunol; 2024; 15():1323307. PubMed ID: 38404571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropil-like islands are a possible pathogenetic link between glioblastoma and gangliocytoma/ganglioglioma in a case of synchronous bilateral brain tumors.
    Ishizawa K; Adachi JI; Tamaru JI; Nishikawa R; Mishima K; Sasaki A
    Neuropathology; 2024 Apr; 44(2):126-134. PubMed ID: 37641451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
    Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
    J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
    Appin CL; Hong C; Suwala AK; Hilz S; Mathur R; Solomon DA; Smirnov IV; Stevers NO; Shai A; Wang A; Berger MS; Chang SM; Phillips JJ; Costello JF
    Neuro Oncol; 2024 Apr; 26(4):640-652. PubMed ID: 38141254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.
    Ohba S; Mukherjee J; Johannessen TC; Mancini A; Chow TT; Wood M; Jones L; Mazor T; Marshall RE; Viswanath P; Walsh KM; Perry A; Bell RJ; Phillips JJ; Costello JF; Ronen SM; Pieper RO
    Cancer Res; 2016 Nov; 76(22):6680-6689. PubMed ID: 27758882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
    Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
    J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Meel M; Jindal A; Kumar M; Mathur K; Singh A
    Asian J Neurosurg; 2024 Mar; 19(1):14-20. PubMed ID: 38751398
    [No Abstract]   [Full Text] [Related]  

  • 11. Telomerase Reverse Transcriptase-Promoter Mutation in Young Patients with Bladder Tumors.
    Pérez González S; Heredia-Soto V; Girón de Francisco M; Pérez-Fernández E; Casans-Francés R; Mendiola Sabio M; González-Peramato P
    Curr Issues Mol Biol; 2024 Mar; 46(4):2845-2855. PubMed ID: 38666908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.
    Arita H; Yamasaki K; Matsushita Y; Nakamura T; Shimokawa A; Takami H; Tanaka S; Mukasa A; Shirahata M; Shimizu S; Suzuki K; Saito K; Kobayashi K; Higuchi F; Uzuka T; Otani R; Tamura K; Sumita K; Ohno M; Miyakita Y; Kagawa N; Hashimoto N; Hatae R; Yoshimoto K; Shinojima N; Nakamura H; Kanemura Y; Okita Y; Kinoshita M; Ishibashi K; Shofuda T; Kodama Y; Mori K; Tomogane Y; Fukai J; Fujita K; Terakawa Y; Tsuyuguchi N; Moriuchi S; Nonaka M; Suzuki H; Shibuya M; Maehara T; Saito N; Nagane M; Kawahara N; Ueki K; Yoshimine T; Miyaoka E; Nishikawa R; Komori T; Narita Y; Ichimura K
    Acta Neuropathol Commun; 2016 Aug; 4(1):79. PubMed ID: 27503138
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Arora I; Gurav M; Rumde R; Dhanavade S; Kadam V; Kurani H; Shetty O; Goda JS; Shetty P; Moiyadi A; Gupta T; Jalali R; Epari S
    Neurol India; 2018; 66(4):1106-1114. PubMed ID: 30038102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase promoter mutation- and O
    Gramatzki D; Felsberg J; Hentschel B; Wolter M; Schackert G; Westphal M; Regli L; Thon N; Tatagiba M; Wick W; Schlegel U; Krex D; Matschke J; Roth P; Suresh MP; Kamp MA; Rushing EJ; Pietsch T; von Deimling A; Sabel M; Loeffler M; Weller M; Reifenberger G
    Eur J Cancer; 2021 Apr; 147():84-94. PubMed ID: 33631540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma biology and molecular markers.
    Cohen AL; Colman H
    Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.
    Internò V; Triggiano G; De Santis P; Stucci LS; Tucci M; Porta C
    Front Oncol; 2022; 12():866623. PubMed ID: 35756624
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Barange M; Epari S; Gurav M; Shetty O; Sahay A; Shetty P; Goda J; Moyiadi A; Gupta T; Jalali R
    Neurol India; 2021; 69(1):126-134. PubMed ID: 33642283
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.